HuidaGene Therapeutics

Second child’s death in China gene-editing trial disclosed after months of silence

The deaths of two children in separate gene-editing clinical trials in China have come to light in rapid succession, intensifying scrutiny over the country's regulatory framework for cutting-edge medical research and the transparency of investigator-led studies.